

Dr. Liam J. Cameau is a Haitian-American political scientist, jurist, neuroscientist, researcher, and board-certified neuro-psychiatric physician. He is a member of the Royal College of Physicians and Surgeons of England, reflecting his distinguished standing within the international medical community.
Renowned for his interdisciplinary expertise, Dr. Cameau integrates medicine, neuroscience, public policy, and global development to address complex health and governance challenges. His work bridges clinical excellence with strategic leadership, positioning him at the forefront of innovation in both healthcare and humanitarian affairs.
Entrepreneurial Leadership in Biopharmaceutical Innovation
Dr. Cameau is widely recognized as a business magnate, drug manufacturer, drug developer, and philanthropist. He is the founder of two globally recognized biopharmaceutical enterprises:
Organo Meta Green
A biopharmaceutical and skincare company specializing in natural, plant-based formulations enhanced with advanced cosmeceuticals. Organo Meta Green positions itself as a leader in biopharma research, with initiatives in mRNA science, vaccine development, and medical dermatology. The company merges botanical innovation with clinical-grade biotechnology, advancing next-generation healthcare solutions.
Reliance BioPharma & Pharmaceuticals Group LLC
A Contract Development and Manufacturing Organization (CDMO) delivering integrated solutions across the biopharmaceutical industry. The organization provides comprehensive services including drug development, clinical trials management, laboratory support, lab informatics, equipment services, and biotech training programs. With expertise spanning cell biology, genome editing, and food safety (PASS program), the company supports innovation from discovery through commercialization.
Together, these enterprises serve the life sciences sector by accelerating efficiency, fostering innovation, and delivering high-quality biopharmaceutical products to global markets. Their shared mission is to advance healthcare through scientific excellence, strategic partnerships, and transformative research.
Humanitarian Leadership and Global Impact
Beyond the corporate sphere, Dr. Cameau is the founder of World Relief Organizations, Inc., a nonprofit dedicated to improving quality of life worldwide through health, education, and sustainable development initiatives.
World Relief Organizations, Inc. operates locally in various U.S. states as:
• NYS Children and Family Community Services (NYS-CFCS)
• Cosmopolitan Community Fostered Services (CCFS)
It also extends its humanitarian footprint across Canadian provinces, including Ontario and Quebec, particularly in Montreal. Through these initiatives, Dr. Cameau has advanced community-centered models focused on child welfare, social services, and sustainable development.
International Engagement and Peacebuilding
Dr. Cameau has participated in numerous international missions and programs associated with major global institutions, including:
• United Nations Peace and Security initiatives
• United Nations Peacekeeping (“Blue Helmets”)
• United Nations Office for Project Services (UNOPS)
• International Organization for Migration (IOM UN Migration)
• European Union (EU)
• The Government of Canada through embassies and agencies
Through these collaborations, he has contributed to humanitarian response, development programs, and peace and security operations on a global scale.
Vision and Legacy
Dr. Liam J. Cameau’s vision centers on expanding humanitarian, development, and peacebuilding initiatives through enhanced implementation capacity alongside the United Nations and international partners. His mission is to deliver measurable impact where it is needed most—strengthening healthcare systems, empowering communities, and fostering global stability.
By uniting scientific innovation, corporate leadership, and humanitarian service, Dr. Cameau represents a multidimensional leader dedicated to advancing global health, sustainable development, and international peace.
Organo Meta Green is one of the largest biopharma companies in North America working with multiple other biopharma worldwide.
We have:
We are a center of excellence for Clinical Trial Material (CTM) Phase I/II/III and Commercial manufacturing of solid oral dosages and injectable drugs through legacy manufacturing sites. Our manufacturing technologies include immediate release (IR), modified release (Delayed Release, Sustained Release, and Customer Release), and enabling technologies (Solvent/Aqueous Spray Drying and Hot-Melt Extrusion) for granules, pellets, multi-particulates, powders, sprinkles in the form of tablets.
At Organo Meta Green, we are dedicated to promoting optimal health and well-being through our exceptional line of natural vitamins and supplements. Our physician-grade formulas are meticulously crafted with non-GMO ingredients sourced from the purest regions of the world. We take pride in enhancing the absorption of our supplements naturally, ensuring that you experience the best possible results.
At Organo Meta Green, we conduct cutting-edge research and testing to develop biopharmaceuticals derived from living organisms. Utilizing advanced technology and data-driven research, we are revolutionizing the way medications and vaccines are made. With a global network of resources and a focus on healthcare treatment, prevention, and overall wellness, we deliver high-quality drugs, vaccines, and therapies. Partner with us to shape the future of healthcare.
Our commitment to excellence in quality, extensive research, and development sets us apart in the industry. Join us on our journey to transform healthcare and improve lives globally.
Medication prescribing